Some may experience mild digestive upset, though this is less common, contact our office if you are in need of Zofran (nausea medication)
Solutions for a Sluggish Metabolism with GLOW Peptide Therapy: While not a direct weight-loss solution, the GLOW Peptide protocol creates a metabolic environment that is more conducive to fat loss
Supporting your AOD-9604 protocol The peptide does not work in isolation
In terms of sphingolipids metabolism, the rs267734 gene variant of Ceramide synthases 2 (CerS2) in patients with DKD resulted in increased proteinuria (108), and polymorphisms in the Sphingosine-1-phosphate lyase 1(SGPL1) gene encoding S1P lyase 1 were associated with reduced enzymatic activity of S1P lyase 1 and the development of nephropathy
Factors influencing outcomes may include: Age Injury severity Lifestyle habits Nutrition Overall health status Treatment adherence No outcome can be guaranteed
Reach out for professional support if: Your baby isnt gaining weight properly
